• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Preventive effects of SGLT2 inhibitors on incident hypertension in patients with diabetes who do not have hypertension.

作者信息

Maruhashi Tatsuya, Higashi Yukihito

机构信息

Department of Cardiovascular Regeneration and Medicine, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.

Division of Regeneration and Medicine, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan.

出版信息

Hypertens Res. 2024 Jul;47(7):1892-1893. doi: 10.1038/s41440-024-01696-6. Epub 2024 Apr 24.

DOI:10.1038/s41440-024-01696-6
PMID:38658652
Abstract
摘要

相似文献

1
Preventive effects of SGLT2 inhibitors on incident hypertension in patients with diabetes who do not have hypertension.钠-葡萄糖协同转运蛋白2抑制剂对无高血压的糖尿病患者新发高血压的预防作用
Hypertens Res. 2024 Jul;47(7):1892-1893. doi: 10.1038/s41440-024-01696-6. Epub 2024 Apr 24.
2
Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetes.钠-葡萄糖共转运蛋白 2 抑制剂与真实世界 2 型糖尿病患者帕金森病风险的关系。
Diabetes Obes Metab. 2024 Dec;26(12):5727-5736. doi: 10.1111/dom.15943. Epub 2024 Sep 10.
3
Sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase IV inhibitors and risk of dementia among patients with type 2 diabetes and comorbid mental disorders: A population-based cohort study.2型糖尿病合并精神障碍患者中，钠-葡萄糖协同转运蛋白2抑制剂与二肽基肽酶IV抑制剂及痴呆风险：一项基于人群的队列研究。
Diabetes Metab. 2024 Nov;50(6):101581. doi: 10.1016/j.diabet.2024.101581. Epub 2024 Sep 28.
4
Dipeptidyl peptidase 4 inhibitors, sodium glucose cotransporter 2 inhibitors, and glucagon-like peptide 1 receptor agonists do not worsen diabetic macular edema.二肽基肽酶 4 抑制剂、钠-葡萄糖共转运蛋白 2 抑制剂和胰高血糖素样肽 1 受体激动剂不会加重糖尿病性黄斑水肿。
J Diabetes Complications. 2024 Aug;38(8):108808. doi: 10.1016/j.jdiacomp.2024.108808. Epub 2024 Jul 14.
5
Sodium-glucose cotransporter 2 inhibitors and inverse risk of new-onset atopic dermatitis in a cohort with diabetes: a nationwide active-comparator study.钠-葡萄糖协同转运蛋白2抑制剂与糖尿病队列中新发特应性皮炎的反向风险：一项全国性活性对照研究
Br J Dermatol. 2025 Jun 20;193(1):74-84. doi: 10.1093/bjd/ljaf086.
6
Effects of Sodium-glucose Cotransporter 2 Inhibitor Monotherapy on Weight Changes in Patients With Type 2 Diabetes Mellitus: a Bayesian Network Meta-analysis.钠-葡萄糖共转运蛋白 2 抑制剂单药治疗对 2 型糖尿病患者体重变化的影响：一项贝叶斯网状 Meta 分析。
Clin Ther. 2019 Feb;41(2):322-334.e11. doi: 10.1016/j.clinthera.2019.01.001. Epub 2019 Jan 30.
7
The effect of sodium-glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM.钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者糖化血红蛋白变异性及心血管和肾脏不良结局的影响
Diabetes Obes Metab. 2025 Sep;27(9):4720-4728. doi: 10.1111/dom.16509. Epub 2025 Jun 13.
8
Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study.肾素-血管紧张素系统（RAS）抑制剂和钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂单用或联用对糖尿病合并高血压患者终末期肾病和/或全因死亡的影响：一项全国性队列研究
Cardiovasc Diabetol. 2025 Jul 14;24(1):288. doi: 10.1186/s12933-025-02846-x.
9
Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury.新型降糖药物致急性肾损伤风险的网状 Meta 分析。
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):70-78. doi: 10.2215/CJN.11220720. Epub 2020 Dec 29.
10
Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients.钠-葡萄糖共转运蛋白 2 抑制剂的有利的多效性作用：与 2 型糖尿病患者的二肽基肽酶-4 抑制剂的头对头比较。
Cardiovasc Diabetol. 2020 Feb 12;19(1):17. doi: 10.1186/s12933-020-0990-2.

引用本文的文献

1
Emerging therapeutic frontiers in hypertension management.高血压管理中的新兴治疗前沿。
Front Cardiovasc Med. 2025 May 16;12:1550181. doi: 10.3389/fcvm.2025.1550181. eCollection 2025.
2
Interaction and combined effect of triglyceride-glucose index and hypertension on type 2 diabetes individuals' peripheral arterial disease risk.甘油三酯-葡萄糖指数与高血压对2型糖尿病患者外周动脉疾病风险的相互作用及联合效应
Acta Diabetol. 2024 Oct 26. doi: 10.1007/s00592-024-02391-1.

本文引用的文献

1
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2022 年美国糖尿病协会（ADA）和欧洲糖尿病研究协会（EASD）的共识报告：2 型糖尿病患者高血糖管理。
Diabetologia. 2022 Dec;65(12):1925-1966. doi: 10.1007/s00125-022-05787-2. Epub 2022 Sep 24.
2
Cardiovascular risk in patients receiving antihypertensive drug treatment from the perspective of endothelial function.从内皮功能的角度看接受降压药物治疗的患者的心血管风险。
Hypertens Res. 2022 Aug;45(8):1322-1333. doi: 10.1038/s41440-022-00936-x. Epub 2022 May 20.
3
Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease.
糖尿病中的高血压：基础机制和临床疾病的更新。
Hypertension. 2021 Nov;78(5):1197-1205. doi: 10.1161/HYPERTENSIONAHA.121.17981. Epub 2021 Oct 4.
4
Hypertension with diabetes mellitus: significance from an epidemiological perspective for Japanese.伴发糖尿病的高血压：从日本的流行病学角度看其重要性。
Hypertens Res. 2017 Sep;40(9):795-806. doi: 10.1038/hr.2017.67. Epub 2017 Jul 13.
5
Effects of dipeptidyl peptidase-4 inhibitors on blood pressure in patients with type 2 diabetes: A systematic review and meta-analysis.二肽基肽酶-4抑制剂对2型糖尿病患者血压的影响：一项系统评价和荟萃分析。
J Hypertens. 2016 Feb;34(2):167-75. doi: 10.1097/HJH.0000000000000782.
6
Cardiovascular risk with and without antihypertensive drug treatment in the Japanese general population: participant-level meta-analysis.日本一般人群中降压药物治疗与未治疗的心血管风险：参与者水平的荟萃分析。
Hypertension. 2014 Jun;63(6):1189-97. doi: 10.1161/HYPERTENSIONAHA.113.03206. Epub 2014 Mar 17.
7
Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis.钠-葡萄糖协同转运蛋白2抑制剂对血压的影响：一项系统评价和荟萃分析。
J Am Soc Hypertens. 2014 Apr;8(4):262-75.e9. doi: 10.1016/j.jash.2014.01.007. Epub 2014 Jan 26.
8
Diabetes mellitus and vascular disease.糖尿病和血管疾病。
Hypertension. 2013 May;61(5):943-7. doi: 10.1161/HYPERTENSIONAHA.111.00612.
9
Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study.治疗的高血压和高脂血症患者的残余心血管风险：PRIME 研究。
J Hum Hypertens. 2010 Jan;24(1):19-26. doi: 10.1038/jhh.2009.34.